Current controversies in data monitoring for clinical trials.


Pocock, SJ; (2006) Current controversies in data monitoring for clinical trials. Clinical trials (London, England), 3 (6). pp. 513-21. ISSN 1740-7745 DOI: https://doi.org/10.1177/1740774506073467

Full text not available from this repository. (Request a copy)

Abstract

This article presents some real-life challenges faced by clinical trial Data Monitoring Committees (DMCs), with the aim of clarifying some of the controversial issues that relate to both statistical stopping boundaries and DMC decision-making. Specific attention is given to what constitutes a sensible statistical boundary for stopping a trial early for benefit, bearing in mind that one usually needs proof beyond reasonable doubt of a treatment benefit sufficient to alter future clinical practice. Appropriate choices of stopping boundary for harm and futility are also discussed. The examples serve to illustrate that the practicalities of DMC decision-making require wise judgements based on a totality of evidence, making any statistical boundary just an objective guideline rather than a definitive stopping rule.

Item Type: Article
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Medical Statistics
PubMed ID: 17170035
Web of Science ID: 243265400005
URI: http://researchonline.lshtm.ac.uk/id/eprint/10677

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
257Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item